Glenmark Pharma is recalling close to 15 lakh bottles of a generic medication used in the treatment of ADHD in the US market, the US health regulator said. The company is recalling the lot due to “CGMP deviations”, the regulator USFDA said. The recall is due to “presence of N-Nitroso Atomoxetine impurity above the FDA recommended limit,” it added. agencies
Glenmark recalls ADHD medicine bottles in US
Date:
More like thisRelated
Nandita Das on ‘1947 Earth’: I really hope 26 years later somebody will make it more accessible – Exclusive |
Deepa Mehta’s ‘1947 Earth’ recently turned 26...
Scientists detect ‘geological heartbeat’ that could split Africa and create a new ocean |
Scientists have discovered a dramatic geological process...
UK PM removes Mandelson as US ambassador over fresh Epstein revelations
The United Kingdom prime minister has directed...
‘Vote-chori slogan spreading like fire’: Rahul Gandhi vows to share ‘explosive’ proof; slams NDA | India News
NEW DELHI: Congress leader Rahul Gandhi on...